CLINICAL AND EXPERIMENTAL ALLERGY

CLINICAL AND EXPERIMENTAL ALLERGY Journal

publication venue for

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studies. 52:244-249. 2022
A responder analysis to demonstrate dupilumab treatment effect across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) 2021

International Standard Serial Number (ISSN)

0954-7894

Electronic International Standard Serial Number (EISSN)

1365-2222